Department of Oral Surgery and Oral Medicine, University of Oslo, Oslo, Norway; The Norwegian Dry Eye Clinic, Oslo, Norway.
The Norwegian Dry Eye Clinic, Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Ocul Surf. 2020 Oct;18(4):583-594. doi: 10.1016/j.jtos.2020.06.002. Epub 2020 Jul 3.
To review the published literature related to application of intense pulsed light (IPL) for treating meibomian gland dysfunction (MGD).
The literature search included the PubMed database and used the keywords "Intense Pulsed Light and Meibomian Gland Dysfunction".
IPL is a new instrumental treatment modality for MGD. This treatment modality was originally developed for use in dermatology and was later adopted in ophthalmology for treating MGD. IPL therapy for MGD can improve tear film stability, meibomian gland functionality, as well as subjective feeling of ocular dryness. However, in the reviewed literature, there was great variability in patient selection, evaluation criteria, and treatment protocols and durations.
Numerous studies report that IPL is effective for treating MGD and a safe procedure. There is great potential for further improvements to the procedure, as large comparative studies employing different treatment modalities are lacking.
回顾与强脉冲光（IPL）治疗睑板腺功能障碍（MGD）相关的已发表文献。
文献检索包括 PubMed 数据库，并使用关键词“强脉冲光和睑板腺功能障碍”。
IPL 是 MGD 的一种新的仪器治疗方式。这种治疗方式最初是为皮肤科开发的，后来被眼科采用来治疗 MGD。IPL 治疗 MGD 可以改善泪膜稳定性、睑板腺功能以及眼部干燥的主观感觉。然而，在回顾的文献中，患者选择、评估标准以及治疗方案和持续时间存在很大的差异。
许多研究报告 IPL 治疗 MGD 是有效且安全的。由于缺乏不同治疗方式的大型比较研究，该程序仍有很大的改进空间。
